[Therapy of alcoholic and non-alcoholic fatty liver].
Stremmel
W
W
Abteilung Innere Medizin IV, Medizinische Universitätsklinik Heidelberg, Bergheimer Strasse 58, 69115 Heidelberg. wolfgang_stremmel@med.uni-heidelberg.de
Blechacz
B
B
Herrmann
T
T
Rost
D
D
Mueller
S
S
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004038:Diet, Reducing; D015444:Exercise; D005234:Fatty Liver / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D005235:Fatty Liver, Alcoholic / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D006519:Hepatitis, Alcoholic / Q000175:diagnosis; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008082:Lipotropic Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology; D008111:Liver Function Tests; D012307:Risk Factors; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000975:Antioxidants; D002756:Cholagogues and Choleretics; D000960:Hypolipidemic Agents; D008082:Lipotropic Agents; D014580:Ursodeoxycholic Acid